Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis
1999

Amphiregulin and Colon Cancer Cell Growth

publication

Author Information

Author(s): Damstrup L, Kuwada S K, Dempsey P J, Brown C L, Hawkey C J, Poulsen H S, Wiley H S, Coffey R J Jr

Primary Institution: Vanderbilt University School of Medicine and Veterans Affairs Medical Center

Hypothesis

How does cell polarity affect EGF receptor-mediated mitogenesis in colon cancer cell lines?

Conclusion

Amphiregulin acts as an autocrine growth factor in colon cancer cells, and its effects on cell proliferation are influenced by the polarity of the cells.

Supporting Evidence

  • Amphiregulin was the most abundant EGFR ligand in the studied colon cancer cell lines.
  • Basolateral administration of neutralizing AR antibodies significantly reduced DNA replication.
  • A single class of high-affinity EGFRs was found in the basolateral compartment.

Takeaway

Amphiregulin helps colon cancer cells grow, and how it works depends on which part of the cell it's acting on.

Methodology

The study involved growing colon cancer cell lines on plastic and polarized monolayers, measuring cell proliferation and EGF receptor binding.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690456

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication